Phio Pharmaceuticals Corp. (PHIO)

1.03 +0.01 (+0.98%) USD  |  NASDAQ  |  Sep 18, 16:00
1.03 0.00 (0.00%) After-Hours: 20:00
More

Phio Pharmaceuticals Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for PHIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
September 02, 2026 --
August 26, 2026 --
August 07, 2026 --
July 23, 2026 --
June 30, 2026 --
May 11, 2026 --
May 08, 2026 --
March 09, 2026 --
March 06, 2026 --
December 31, 2025 --
November 29, 2025 --
November 28, 2025 --
Date Value
November 20, 2025 --
November 17, 2025 --
November 04, 2025 --
October 29, 2025 --
September 30, 2025 --
August 15, 2025 --
August 12, 2025 --
June 30, 2025 --
June 05, 2025 --
December 31, 2024 --
May 14, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Imunon, Inc. Upgrade
Agenus, Inc. Upgrade
Amgen, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
BioCryst Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade